Market Place
Sourcing Support
Cosette Pharma`s Generics Sucralfate Receives Approval in US
13 Nov 2024 //
FDA
Strides receives USFDA approval for Sucralfate OralSuspension, 1gm/10 mL
23 May 2024 //
PRESS RELEASE
Strides receives USFDA approval for Sucralfate Oral Suspension, 1gm/10 Ml
22 May 2024 //
PRESS RELEASE
Abon Pharma Generic Sucralfate Receives Approval in the U.S
21 Mar 2024 //
FDA
Enforcement Report - Week of October 25, 2023
25 Oct 2023 //
FDA
Enforcement Report - Week of September 20, 2023
20 Sep 2023 //
FDA
Zydus Lifesciences Generic Sucralfate Receives Approval in the U.S
03 May 2023 //
FDA
Govt adds 34 new - drugs to essential medicines list, drops 26
13 Sep 2022 //
BUSINESSTODAY
Mylan`s Generic Sucralfate Receives Approval in the U.S.
12 Sep 2022 //
FDA
Mylan`s Generic Carafate, Sucralfate Receives Approval in the U.S.
12 Sep 2022 //
FDA
Enforcement Report - Week of April 13, 2022
13 Apr 2022 //
FDA
Hailing `paradigm shift,` Clayton gets OK to challenge AbbVie
12 Apr 2022 //
FIERCEPHARMA
Clayton and VistaPharm Receive FDA Approval for Sucralfate Oral Suspension
07 Apr 2022 //
PRNEWSWIRE
Vistapharm`s Generic Sucralfate Receives Approval in the U.S.
15 Mar 2022 //
FDA
Endo Begins Shipment of Authorized Generic Version of Carafate® (sucralfate)
28 Jan 2020 //
PR NEWSWIRE
Amneal Pharmaceutical`s Generic Sucralfate Receives Approval in US
02 Dec 2019 //
FDA
Chugai Pharma sells Ulcerlmin business to Fuji Chemical
02 Apr 2019 //
BIOSPECTRUMASIA
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.